First-in-Man Fully Percutaneous Complete Bypass of Heart ...veno-arterial-pulmonary-arterial (VAPa)...

3
IMAGES IN INTERVENTION First-in-Man Fully Percutaneous Complete Bypass of Heart and Lung L. Christian Napp, MD, a Jens Vogel-Claussen, MD, b Andreas Schäfer, MD, a Axel Haverich, MD, c Johann Bauersachs, MD, a Christian Kühn, MD, c Jörn Tongers, MD a A 24-year-old man was admitted to a regional hospital after an attempted suicide by taking 9 g of the antidepressant venlafaxine. After initial seizures, overnight progressive cardiogenic shock developed (1,2) and resulted in cardiac arrest from electromechanical dissociation (EMD) 12 h after ingestion. Femoral venoarterial extracorporeal membrane oxygenation (VA-ECMO) was inserted under continued cardiopulmonary resuscitation. On arrival at our center the patient had persistent cardiac arrest (EMD) on VA-ECMO support (ow, 5.5 l/min). Coronary artery disease was absent on angiography. The left ventricle (LV) was severely dilated (left ventricular end-diastolic pressure, 36 mm Hg) (Online Video 1) with most seg- ments being akinetic. Massive pulmonary congestion caused by functional cardiac arrest and a toxic effect of venlafaxine (3) was present, necessitating repetitive endotracheal suctioning. For re-establishing trans- pulmonary blood ow (Online Video 2) and unloading the LV, an Impella CP microaxial pump (Abiomed, Danvers, Massachusetts) was inserted (Figure 1). However, Impella ow was very unstable because of persistent right ventricular arrest (Online Video 2), and pulmonary gas exchange was almost impossible. Therefore we expanded the system to a novel form of mechanical support. A exible 15-F ECMO cannula was introduced via the right internal jugular vein into the pulmonary artery (Figure 1) over a stiff Amplatz guidewire and connected to the ECMO outow (veno-arterial- pulmonary-arterial cannulation [VAPa]) (4). Now the ECMO drained 5.5 l/min from the right atrium and returned 2 to 3 l/min to the pulmonary artery and 2.5 to 3.5 l/min toward the aorta, as adjusted by a clamp. The failing right ventricle was bypassed and preoxy- genated blood supplied to the pulmonary artery was consecutively drained from the failing LV by the Impella. As a result, upper and lower body gas ex- change was completely taken over by the ECMO, and systemic and pulmonary circulatory function was taken over by the triple cannulated ECMO and the Impella. The LV consecutively regained pulsatility, cate- cholamine use decreased, and respiratory function recovered (Figure 2). After 6 days ECMO and Impella could be explanted. The patient was weaned from mechanical ventilation, fully mobilized, and ulti- mately transferred to rehabilitation with normalized cardiac function (Online Video 3), chest radiograph, From the a Cardiac Arrest Center, Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany; b Institute for Diagnostic and Interventional Radiology, Hannover Medical School, Hannover, Germany; and the c Department of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany. This study was supported by the German Research Foundation (Clinical Research Unit 311). The authors received no funding for the present work and there was no sponsor or funder involved. The work is fully investigator-initiated. Dr. Napp has received travel support to congresses from Abiomed; and lecture honoraria from Maquet. Dr. Vogel-Claussen is an advisor to Boehringer Ingelheim, Novartis, Parexel, and Bayer; and has received research support from Siemens Healthineers. Dr. Schäfer has received lecture honoraria and research funding from Abiomed. Dr. Haverich has received lecture honoraria from Xenios/Medos. Dr. Bauersachs has received lecture honoraria and research funding from Abiomed. Dr. Kühn has received lecture honoraria from Maquet. Dr. Tongers has received travel support and lecture honoraria from Abiomed. Drs. Kühn and Tongers contributed equally to this paper. Manuscript received May 22, 2017; revised manuscript received June 27, 2017, accepted July 11, 2017. JACC: CARDIOVASCULAR INTERVENTIONS VOL. 10, NO. 24, 2017 ª 2017 BY THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION PUBLISHED BY ELSEVIER ISSN 1936-8798/$36.00 http://dx.doi.org/10.1016/j.jcin.2017.07.047

Transcript of First-in-Man Fully Percutaneous Complete Bypass of Heart ...veno-arterial-pulmonary-arterial (VAPa)...

Page 1: First-in-Man Fully Percutaneous Complete Bypass of Heart ...veno-arterial-pulmonary-arterial (VAPa) extracorporeal membrane oxygenation (ECMO) (B, solid line) to venoarterial (VA)

J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S VO L . 1 0 , N O . 2 4 , 2 0 1 7

ª 2 0 1 7 B Y T H E AM E R I C A N C O L L E G E O F C A R D I O L O G Y F O U N D A T I O N

P U B L I S H E D B Y E L S E V I E R

I S S N 1 9 3 6 - 8 7 9 8 / $ 3 6 . 0 0

h t t p : / / d x . d o i . o r g / 1 0 . 1 0 1 6 / j . j c i n . 2 0 1 7 . 0 7 . 0 4 7

IMAGES IN INTERVENTION

First-in-Man Fully PercutaneousComplete Bypass of Heart and Lung

L. Christian Napp, MD,a Jens Vogel-Claussen, MD,b Andreas Schäfer, MD,a Axel Haverich, MD,c

Johann Bauersachs, MD,a Christian Kühn, MD,c Jörn Tongers, MDa

A 24-year-old man was admitted to a regionalhospital after an attempted suicide by taking9 g of the antidepressant venlafaxine. After

initial seizures, overnight progressive cardiogenicshock developed (1,2) and resulted in cardiac arrestfrom electromechanical dissociation (EMD) 12 h afteringestion.

Femoral venoarterial extracorporeal membraneoxygenation (VA-ECMO)was inserted under continuedcardiopulmonary resuscitation. On arrival at our centerthe patient had persistent cardiac arrest (EMD) onVA-ECMO support (flow, 5.5 l/min). Coronary arterydisease was absent on angiography. The left ventricle(LV)was severely dilated (left ventricular end-diastolicpressure, 36 mm Hg) (Online Video 1) with most seg-ments being akinetic. Massive pulmonary congestioncaused by functional cardiac arrest and a toxic effect ofvenlafaxine (3) was present, necessitating repetitiveendotracheal suctioning. For re-establishing trans-pulmonary blood flow (Online Video 2) and unloadingthe LV, an Impella CP microaxial pump (Abiomed,Danvers, Massachusetts) was inserted (Figure 1).However, Impella flow was very unstable because ofpersistent right ventricular arrest (Online Video 2),and pulmonary gas exchange was almost impossible.

From the aCardiac Arrest Center, Department of Cardiology and AngiologbInstitute for Diagnostic and Interventional Radiology, Hannover Medical S

Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical Sch

by the German Research Foundation (Clinical Research Unit 311). The author

was no sponsor or funder involved. The work is fully investigator-initiated.

from Abiomed; and lecture honoraria from Maquet. Dr. Vogel-Claussen is an

and Bayer; and has received research support from Siemens Healthineers. Dr

funding from Abiomed. Dr. Haverich has received lecture honoraria from

honoraria and research funding from Abiomed. Dr. Kühn has received lectu

travel support and lecture honoraria from Abiomed. Drs. Kühn and Tongers

Manuscript received May 22, 2017; revised manuscript received June 27, 201

Therefore we expanded the system to a novel form ofmechanical support.

A flexible 15-F ECMO cannula was introduced viathe right internal jugular vein into the pulmonaryartery (Figure 1) over a stiff Amplatz guidewireand connected to the ECMO outflow (veno-arterial-pulmonary-arterial cannulation [VAPa]) (4). Now theECMO drained 5.5 l/min from the right atrium andreturned 2 to 3 l/min to the pulmonary artery and 2.5to 3.5 l/min toward the aorta, as adjusted by a clamp.The failing right ventricle was bypassed and preoxy-genated blood supplied to the pulmonary artery wasconsecutively drained from the failing LV by theImpella. As a result, upper and lower body gas ex-change was completely taken over by the ECMO, andsystemic and pulmonary circulatory function wastaken over by the triple cannulated ECMO and theImpella.

The LV consecutively regained pulsatility, cate-cholamine use decreased, and respiratory functionrecovered (Figure 2). After 6 days ECMO and Impellacould be explanted. The patient was weaned frommechanical ventilation, fully mobilized, and ulti-mately transferred to rehabilitation with normalizedcardiac function (Online Video 3), chest radiograph,

y, Hannover Medical School, Hannover, Germany;

chool, Hannover, Germany; and the cDepartment of

ool, Hannover, Germany. This study was supported

s received no funding for the present work and there

Dr. Napp has received travel support to congresses

advisor to Boehringer Ingelheim, Novartis, Parexel,

. Schäfer has received lecture honoraria and research

Xenios/Medos. Dr. Bauersachs has received lecture

re honoraria from Maquet. Dr. Tongers has received

contributed equally to this paper.

7, accepted July 11, 2017.

Page 2: First-in-Man Fully Percutaneous Complete Bypass of Heart ...veno-arterial-pulmonary-arterial (VAPa) extracorporeal membrane oxygenation (ECMO) (B, solid line) to venoarterial (VA)

FIGURE 1 Total Percutaneous Mechanical Support of Cardiopulmonary Failure

On arrival the patient had functional cardiac arrest (Online Videos 1 and 2) on veno-arterial (VA) extracorporeal membrane oxygenation

(ECMO) support and severe lung failure. An Impella microaxial pump was inserted into the left ventricle and VA-ECMO was escalated to

veno-arterial-pulmonary-arterial (VAPa) ECMO by introducing a third cannula into pulmonary artery position. This approach overall resulted in

a circulatory bypass of both ventricles and fully extracorporeal gas exchange. (A) Schematic. (B) Picture of the patient. (C) Computed

tomography.

Napp et al. J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S V O L . 1 0 , N O . 2 4 , 2 0 1 7

Total Mechanical Cardiopulmonary Support D E C E M B E R 2 6 , 2 0 1 7 : e 2 3 1 – 3

e232

and full clinical neurological recovery after 28 days ofhospitalization (Figure 2).

In contrast to conventional single or combinedmechanical support, the presented novel strategytruly bypasses biventricular heart and lung failureand maintains antegrade transpulmonary flow.

ADDRESS FOR CORRESPONDENCE: Dr. L. ChristianNapp, Department of Cardiology and Angiology,Hannover Medical School, Carl-Neuberg-Strasse 1,30625 Hannover, Germany. E-mail: [email protected].

RE F E RENCE S

1. Batista M, Dugernier T, Simon M, et al. Thespectrum of acute heart failure after venlafaxineoverdose. Clin Toxicol (Phila) 2013;51:92–5.

2. Neil CJ, Chong CR, Nguyen TH, Horowitz JD.Occurrence of Tako-Tsubo cardiomyopathy in as-sociationwith ingestion of serotonin/noradrenalinereuptake inhibitors. Heart Lung Circ 2012;21:203–5.

3. Drent M, Singh S, Gorgels AP, et al.Drug-induced pneumonitis and heart failure

simultaneously associated with venlafaxine.Am J Respir Crit Care Med 2003;167:958–61.

4. Napp LC, Bauersachs J. Triple Cannulation ECMO.In: Firstenberg M, editor. Extracorporeal MembraneOxygenation - Advances in Therapy. InTech 2016:79–99. Available at: https://www.intechopen.com/books/extracorporeal-membrane-oxygenation-advances-in-therapy/triple-cannulation-ecmo.Accessed September 2017.

KEY WORDS cardiopulmonary arrest,ECMO, Impella, microaxial pump,mechanical support, resuscitation,Takotsubo syndrome

APPENDIX For supplemental videos,please see the online version of this paper.

Page 3: First-in-Man Fully Percutaneous Complete Bypass of Heart ...veno-arterial-pulmonary-arterial (VAPa) extracorporeal membrane oxygenation (ECMO) (B, solid line) to venoarterial (VA)

FIGURE 2 Clinical Course of the Patient

(A) Over time the left ventricle regained pulsatility as a surrogate of myocardial recovery (right radial artery measurement). Because of mechanical support

and cytokine adsorption (Cytosorb, Monmouth Junction, New Jersey) catecholamines (left y-axis dobutamine, right y-axis norepinephrine) could be reduced

very early (B), and pulmonary edema progressively improved (C, top row radiograph, bottom row computed tomography). Both allowed downgrading of

veno-arterial-pulmonary-arterial (VAPa) extracorporeal membrane oxygenation (ECMO) (B, solid line) to venoarterial (VA) ECMO (B, dashed line). ECMO

and Impella were explanted on Day 7. (D) The patient was sent to rehabilitation 28 days after admission with normalized systolic cardiac function (Online

Video 3) on his own feet. ECMO ¼ extracorporeal membrane oxygenation; VA ¼ venoarterial; other abbreviation as in Figure 1.

J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S V O L . 1 0 , N O . 2 4 , 2 0 1 7 Napp et al.D E C E M B E R 2 6 , 2 0 1 7 : e 2 3 1 – 3 Total Mechanical Cardiopulmonary Support

e233